II. Epidemiology
- Incidence: 1 in up to 7,000 pregnancies
III. Pathophysiology
- Idiopathic condition
- Abnormal hepatic mitochondrial function
- Results in buildup of fat droplets (microvesicular fatty infiltration) in hepatocytes
IV. Risk Factors
- First pregnancy
- Multiple Gestation
V. Symptoms
- Onset in third trimester
- Vomiting (76%)
- Upper Abdominal Pain (43%)
- Anorexia (21%)
- Jaundice (16%)
VI. Signs
VII. Labs
- 
                          Liver Function Tests- Serum Bilirubin increased, but <5 mg/dl
- Prothrombin Time (aPT and INR) increased
- Serum Transaminases (AST, ALT) <500 IU/L- Contrast with much higher in Viral Hepatitis
 
- PTT and INR/ProTime prolonged
 
- 
                          Platelet Count decreased mildly: 100,000 to 150,000- Contrast with HELLP Syndrome in which Platelet Count is much lower
 
- Chemistry panel- Serum Creatinine increased
- Hypoglycemia
 
VIII. Imaging
- All imaging tests have high False Positive Rate
- 
                          Abdominal Ultrasound
                          - Evaluate for hepatic infarct, Hematoma and Acute Cholecystitis
 
IX. Differential Diagnosis
- See Acute Hepatitis
- 
                          Hyperemesis Gravidarum
                          - Liver transaminases (AST, ALT) may be over 200 IU/L
- Alkaline Phosphatase may be increased up to twice normal
- Serum Bilirubin may be increased enough to cause visible Jaundice
 
- 
                          HELLP Syndrome
                          - May be most difficult to distinguish from Acute Fatty Liver of Pregnancy
- Often associated with Preeclampsia with Severe Hypertension and Proteinuria
- Most commonly occurs in third trimester and immediately postpartum
 
- Acute Fatty Liver of Pregnancy- Associated with more severe liver failure and Renal Insufficiency
- May be difficult to distinguish with HELLP Syndrome
 
- 
                          Intrahepatic Cholestasis of Pregnancy
                          - Most common liver disease in pregnancy (second and third trimester)
- Significantly elevated Bilirubin levels risk fetal demise and preterm delivery
 
- Other Acute Liver Disease- See Acute Hepatitis
- Hepatic infarct
- Trauma (Liver Hematoma)
- Acute Cholecystitis
 
X. Differential Diagnosis: Non-pregnancy related
XI. Management
- Distinguish from HELLP Syndrome (and other causes of liver disease in pregnancy)- See Differential Diagnosis above
- Severe hepatic insufficiency is more likely in Acute Fatty Liver of Pregnancy (AFLP) than HELLP- Encephalopathy, Coagulopathy and Hypoglycemia are more common in AFLP
 
 
- Delivery is critical and should be performed as soon as possible- Delay may result in disease progression with risk of maternal mortality
- Delivery regardless of Gestational Age
 
- Avoid Hepatotoxins (e.g. certain general Anesthetics)
- Treat concurrent Disseminated Intravascular Coagulation- Correct Coagulopathy with Blood Products
 
- Correct Hypoglycemia- D10W infusion and
- Dextrose 50% boluses as needed
 
XII. Course
- Fulminant hepatic failure if untreated
- Disease usually remits within days of delivery (although lab abnormalities may persist)
XIII. Prognosis
- Maternal mortality: <10% (previously as high as 92%)
- Infant mortality: Previously as high as 50%
XIV. Complications
- Acute Liver Failure
- Acute Renal Failure
- Acute Pancreatitis
- Disseminated Intravascular Coagulation
- Uncontrolled Hemorrhage
- Maternal death
XV. References
- Swencki (2015) Crit Dec Emerg Med 29(11):2-10
- Castro (1999) Am J Obstet Gynecol 181:389-95 [PubMed]
